Reviva Pharmaceuticals Holdings, Inc.RVPHNASDAQ
Loading
SG&A Expense Growth Under PressureDecelerating
Percentile Rank0
Studio
Year-over-Year Change

Year-over-year SG&A expense growth

Percentile
P0
Near historical low
vs 5Y Ago
-0.8x
Contraction
Streak
1 yr
Consecutive declineDecelerating
PeriodValue
2024-2.38%
202350.85%
20222.01%
2021145.52%
20201081.29%
20193.15%
20180.00%